PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 110 filers reported holding PULMONX CORP in Q1 2022. The put-call ratio across all filers is 2.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,318,250 | -69.8% | 275,000 | -40.3% | 0.05% | -73.4% |
| Q3 2022 | $7,678,000 | -24.5% | 460,847 | -33.3% | 0.18% | -32.7% |
| Q2 2022 | $10,175,000 | -48.6% | 691,255 | -13.4% | 0.26% | -35.9% |
| Q1 2022 | $19,805,000 | -47.0% | 798,255 | -31.5% | 0.41% | -24.8% |
| Q4 2021 | $37,349,000 | -10.9% | 1,164,600 | 0.0% | 0.54% | -13.8% |
| Q3 2021 | $41,902,000 | -15.9% | 1,164,600 | +3.1% | 0.63% | -16.0% |
| Q2 2021 | $49,838,000 | -3.5% | 1,129,600 | 0.0% | 0.75% | -6.8% |
| Q1 2021 | $51,668,000 | -31.0% | 1,129,600 | 0.0% | 0.81% | -35.7% |
| Q4 2020 | $74,839,000 | – | 1,129,600 | – | 1.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG-WTT Global Life Science Capital Partners GP Ltd | 815,019 | $37,279,000 | 40.66% |
| Yu Fan | 303,030 | $13,861,000 | 36.18% |
| ABG Innovation Capital Partners III GP Ltd | 833,333 | $38,117,000 | 18.73% |
| KPCB XIII Associates, LLC | 994,971 | $45,510,000 | 9.36% |
| Iron Triangle Partners LP | 600,000 | $27,444,000 | 3.49% |
| Miura Global Management | 405,000 | $18,525,000 | 3.31% |
| GREAT POINT PARTNERS LLC | 114,345 | $5,230,000 | 1.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 937,032 | $42,860,000 | 0.90% |
| ADAMS STREET PARTNERS LLC | 114,661 | $5,245,000 | 0.84% |
| RTW INVESTMENTS, LP | 1,129,600 | $51,668,000 | 0.81% |